tradingkey.logo
搜尋

Merck & Co Inc

MRK
添加自選
119.570USD
+4.090+3.54%
收盤 06/23, 16:00美東報價延遲15分鐘
295.39B總市值
33.52本益比TTM

Merck & Co Inc

119.570
+4.090+3.54%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.54%

5天

+3.82%

1月

-2.32%

6月

+13.83%

今年開始到現在

+13.59%

1年

+49.16%

關鍵數據
116.570今開
119.800最高
10.47M成交量
33.52本益比TTM
12.56本益比動
3.320股利TTM
0.42%換手率
115.480昨收
116.570最低
719.45M成交額
17.38本益比靜
5.74市淨率
2.78%股息率 TTM
7.33%ROA
125.14052週最高
0.68量比
17.12B淨利潤
2.49B總股本
3.5675每股盈餘TTM
0.22Beta
18.97%ROE
75.40052週最低
2.80%振幅
75.70%毛利率
295.39B總市值
-3.71回報/風險
1.53%風險率

TradingKey Merck & Co Inc股票評分

單位: USD 更新時間: 2026-06-23

操作建議

Merck & Co Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名37/157位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為129.52。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Merck & Co Inc評分

相關信息

行業排名
37 / 157
全市場排名
80 / 4573
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

48°C

過冷
過熱
看好

Merck & Co Inc亮點

亮點風險
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入65.01B美元
高分紅
公司屬於高分紅公司,最新股息支付率46.40%
穩定分紅
公司5年內持續分紅,最新股息支付率46.40%
估值合理
公司最新PE估值33.53,處於3年歷史合理位
機構減倉
最新機構持股2.01B股,環比減少0.52%
比爾·斯米德持倉
明星投資者比爾·斯米德持倉,最新持倉2.47M股

分析師目標

基於 32 分析師
買入
評級
129.524
目標均價
+12.16%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Merck & Co Inc簡介

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
公司代碼MRK
公司Merck & Co Inc
CEODavis (Robert M)
網址https://www.merck.com/

常見問題

Merck & Co Inc(MRK)的當前股價是多少?

Merck & Co Inc(MRK)的當前股價是 119.57。

Merck & Co Inc 的股票代碼是什麼?

Merck & Co Inc的股票代碼是MRK。

Merck & Co Inc股票的52週最高點是多少?

Merck & Co Inc股票的52週最高點是125.14。

Merck & Co Inc股票的52週最低點是多少?

Merck & Co Inc股票的52週最低點是75.40。

Merck & Co Inc的市值是多少?

Merck & Co Inc的市值是297.41B。

現在Merck & Co Inc(MRK)的股票是買入、持有還是賣出?

根據分析師評級,Merck & Co Inc(MRK)的總體評級為買入,目標價格為129.52。

Merck & Co Inc(MRK)股票的每股收益(EPS TTM)是多少

Merck & Co Inc(MRK)股票的每股收益(EPS TTM)是7.30。
KeyAI